Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy
Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, et al.
Future Virology (2023) Vol. 18, Iss. 3, pp. 177-191
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
Eunju Shin, Seong Ho Bak, Tae‐Ho Park, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Measurement of IFN-γ and IL-2 for the assessment of the cellular immunity against SARS-CoV-2
Guillem Safont, Raquel Villar-Hernández, Daria Smalchuk, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications
Arash Letafati, Omid Salahi Ardekani, Mina Naderisemiromi, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Natural Killer Cell-Derived Extracellular Vesicles, Exosomes, and Microvesicles: Novel Weapons in Support of Immune Response
Serena Cecchetti, Cristina Federici, Luana Lugini
Springer eBooks (2025), pp. 1-24
Closed Access
Navigating the Unknown: Open Questions Surrounding Natural Killer Cell Responses to SARS-CoV-2
Quirin Hammer
Springer eBooks (2025), pp. 1-21
Closed Access
Analysis of the immune response in COVID-19
Altijana Hromić‐Jahjefendić, Alaa A. A. Aljabali
Progress in molecular biology and translational science (2025)
Closed Access
Adoptive transfer of natural killer cells in therapeutic treatment of COVID-19 patients
Abdulaziz Alamri
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Delineating immune variation between adult and children COVID-19 cases and associations with disease severity
Alper Çevirgel, Martijn Vos, Anne Floor Holtrop, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
The central role of natural killer cells in mediating acute myocarditis after mRNA COVID-19 vaccination
Hing Wai Tsang, Mike Yat Wah Kwan, Gilbert T. Chua, et al.
Med (2024) Vol. 5, Iss. 4, pp. 335-347.e3
Open Access | Times Cited: 3
New-Onset Diabetes Mellitus in COVID-19: A Scoping Review
Anca Pantea Stoian, Cristina Bică, Teodor Salmen, et al.
Diabetes Therapy (2023) Vol. 15, Iss. 1, pp. 33-60
Open Access | Times Cited: 8
COVID-19 associated with cryptococcosis: a scoping review
Alvaro Quincho-Lopez, Nuvith Poma, Juan José Montenegro-Idrogo
Therapeutic Advances in Infectious Disease (2024) Vol. 11
Open Access | Times Cited: 2
Reprogramming Tumor-associated Macrophages Using Exosomes from M1 Macrophages
Mohammad Mahmoudi, Mahsa Taghavi-Farahabadi, Seyed Mahmoud Hashemi, et al.
Biochemical and Biophysical Research Communications (2024), pp. 150697-150697
Closed Access | Times Cited: 2
Off-the-Shelf Allogeneic Natural Killer (NK) Cells for the Treatment of COVID-19
Winnie Liu, Eleftheria Kampouri, John Bui, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 4, pp. 101361-101361
Open Access | Times Cited: 2
Post-COVID-19 and Post-COVID-19 Vaccine Arthritis, Polymyalgia Rheumatica and Horton’s Arteritis: A Single-Center Assessment of Clinical, Serological, Genetic, and Ultrasonographic Biomarkers
Francesca Bandinelli, Mario Pagano, Maria Sole Vallecoccia
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7563-7563
Open Access | Times Cited: 7
STUDY OF ACTIVE ISOLATED COMPOUNDS FROM SUNGKAI LEAF (PERONEMA CANESCENS JACK) AS IMMUNOSTIMULANT FROM EXPOSURE OF THE SARS-COV-2 VIRUS ANTIGEN TO NATURAL KILLER CELLS
Dwisari Dillasamola, YUFRI ALDI, FATMA SRI WAHYUNI, et al.
International Journal of Applied Pharmaceutics (2024), pp. 11-16
Open Access | Times Cited: 1
Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus
Guiomar Casado-Fernández, Juan Cantón, Laura Nasarre, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Survive, revive, and thrive: The impact of COVID-19 on global park visitation
Dehui Christina Geng, John L. Innes, Guangyu Wang
The Science of The Total Environment (2024) Vol. 946, pp. 174077-174077
Closed Access | Times Cited: 1
It’s time for a booster: here’s your 19th dose of Future Virology !
Ellen Porter
Future Virology (2024) Vol. 19, Iss. 1, pp. 1-4
Closed Access
Development of a Platform for Natural Killer Cell Therapy with Antiviral Efficacy
Dong-Soo Kim, Hyeongseok Yun, Jinhui Lee, et al.
Journal of the Korea Institute of Military Science and Technology (2024) Vol. 27, Iss. 1, pp. 107-115
Open Access
Resilience and Recovery: The Impact of Covid-19 on Global Park Visitation
Dehui Christina Geng, John L. Innes, Guangyu Wang
(2024)
Closed Access
Integrative genomic analysis of the lung tissue microenvironment in SARS-CoV-2 and NL63 patients
Krithika Bhuvaneshwar, Subha Madhavan, Yuriy Gusev
Heliyon (2024) Vol. 10, Iss. 12, pp. e32772-e32772
Open Access
Cxcl10 is required for survival during SARS-CoV-2 infection in mice
Shamik Majumdar, Joseph D. Weaver, Sergio M. Pontejo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Widespread gene-environment interactions shape the immune response to SARS-CoV-2 infection in hospitalized COVID-19 patients
Haley E. Randolph, Raúl Aguirre‐Gamboa, Elsa Brunet‐Ratnasingham, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Immunological aspects of COVID-19 pathogenesis: a review
Carlos Alfredo Miló-Valdés, Lidia Cecilia Pérez Acevedo
Deleted Journal (2024) Vol. 3
Closed Access
Low-frequency CD8+ T cells induced by SIGN-R1+ macrophage-targeted vaccine confer SARS-CoV-2 clearance in mice
Daisuke Muraoka, Meng Ling Moi, Osamu Muto, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top